Innoviva (INVA) Other financing activities (2013 - 2026)
Innoviva's Other financing activities came in at $94,000 for Q2 2026, up 291.7% from $24,000 a year earlier but down 40.5% from the prior quarter.
Innoviva (INVA) Other financing activities (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Innoviva reported Other financing activities of $304,000, up 137.5% year-over-year; for FY2025, it was $143,000, up 0.7% from FY2024.
- Other financing activities carries a five-year compound annual growth rate of -65.8% (FY2020 to FY2025).
- Going back by year, Other financing activities was $142,000 in FY2024 (+84.4%), $77,000 in FY2023 (-99.9%), $69.81 million in FY2022 (+17.4%) and $59.46 million in FY2021 (+95.1%).
- The five-year range for quarterly Other financing activities is $18,000 (Q3 2024) to $13.1 million (Q4 2021).
- Year-over-year, Other financing activities has increased for five consecutive quarters, with growth averaging 83.8% over the last six quarters.
- The fastest year-over-year change in Other financing activities over five years came in Q4 2021 (growth of 421.5%), and the weakest in Q2 2023 (a decline of 99.7%).
- Business Quant data shows INVA's Other financing activities at $158,000 (Q1 2026), $27,000 (Q4 2025) and $25,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.90 Bn | 1,105.48 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.06 Bn | 535.59 Bn | 17.26 Bn |
| 3 | AbbVie | 501.38 Bn | 474.49 Bn | 12.70 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.92 Bn | 261.91 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.31 Bn | 235.00 Bn | 12.86 Bn |
| 7 | Amgen | 236.29 Bn | 191.69 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.40 Bn | 164.60 Bn | 6.22 Bn |
| 9 | Pfizer | 169.55 Bn | 116.19 Bn | 10.94 Bn |
| 10 | Innoviva | 1.54 Bn | -748.55 Mn | 90.62 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -94,000.00 |
| Mar 31, 2026 | -158,000.00 |
| Dec 31, 2025 | -27,000.00 |
| Sep 30, 2025 | -25,000.00 |
| Jun 30, 2025 | -24,000.00 |
| Mar 31, 2025 | -67,000.00 |
| Dec 31, 2024 | -19,000.00 |
| Sep 30, 2024 | -18,000.00 |
| Jun 30, 2024 | -21,000.00 |
| Mar 31, 2024 | -84,000.00 |
| Jun 30, 2023 | -31,000.00 |
| Mar 31, 2023 | -23,000.00 |
| Jun 30, 2022 | -9.56 Mn |
| Mar 31, 2022 | -6.55 Mn |
| Dec 31, 2021 | -13.11 Mn |
| Sep 30, 2021 | -4.92 Mn |
| Jun 30, 2021 | -20.17 Mn |
| Mar 31, 2021 | -21.31 Mn |
| Dec 31, 2020 | -2.52 Mn |
| Sep 30, 2020 | -11,000.00 |
Innoviva Other financing activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=INVA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();